Our Sectors
We are experts at what we do
01
Our People
A dedicated team of executive search experts, delivering for you
The Compass Carter Osborne team are healthcare and life science experts. As a trusted advisor we bring decades of search experience and an unparalleled track record of delivery across our dedicated sectors for our investor clients – relied upon time and again to build outstanding leadership teams.
Familiar faces at key industry events, our expertise extends beyond the mere placing of people with our consultants bringing together sector leaders to address key challenges, working in partnership to produce tangible solutions.
02
Expertise
Unearthing rare talent, that drive successful exits
Responsive, adaptable, and emotionally intelligent, Compass Carter Osborne avoid the one-size-fits-all approach to ensure our clients achieve their desired outcome by presenting a broad range of intuitive, tailored solutions, based on specific needs.
03
Our Approach
Tailoring our offering,
to provide a bespoke service
Results driven, not process led, CCO avoid the conformity of a rigid process. Never assumptive, we listen and adopt an agreed approach which most closely delivers to a clients specific needs. Understanding the uniqueness of each role, our people tailor a search to bespoke requirements to ensure solutions that delivers the best possible results first time, every time.
A trusted advisor to the investment community
providing leaders advancing the healthcare and life sciences sectors
What our clients say
“Compass Carter Osborne really delivered for us in our search for a new CEO for Outcomes First Group. It was a vitally important assignment given that we were recruiting a successor for a long standing and highly successful CEO in a sector-leading business. Compass Carter Osborne went above and beyond in developing a deep understanding of the business and our requirements, and in only presenting candidates that closely met these. They think very creatively and their focus was very sharp; they particularly understood the culture of the business. The search was speedy and well organised, with a very high standard of verbal and written feedback. They have a granular knowledge of the sector and because of the way in which they work, we were fully involved throughout and achieved a great result. A really excellent search – thank you.”
Outcomes First Group – Chair
“Compass Carter Osborne started from the very beginning with a detailed, professional explanation of the available position. They spent time to present the great opportunity and chance to accelerate my career but at the same time, the challenge, and the strong expectation from their client.”
Hengrui Therapeutics – VP, Head Biological Drug Discovery
“Compass Carter Osborne delivered on a key appointment for the PFA and the wider football industry. It was a complex brief involving creating an entirely new position. The role was vitally important, with the successful candidate taking on a sensitive and multifaceted responsibility across CTE, concussion and brain health in professional football. CCO led a comprehensive and exhaustive process, developing a deep understanding of the union’s requirements and using his expert knowledge to help scope and evolve the brief throughout the search. The entire process was professional, efficient and well organised, with consistent communication and feedback at every stage.”
The Professional Footballers Association (PFA) – Chief Executive Officer
“I have been so impressed by Luke’s integrity, clear purpose and drive to achieve for his clients. Luke has worked with Priory on a number of things but more recently to source two independent Non Executive Directors and a Director of Talent Acquisition. He has kept us informed, fielded some great candidates and follows up at each stage, even when they have started. I would really recommend him if you are searching for high calibre individuals.”
Priory Group – Chief Executive Officer
“I recently had the pleasure of being appointed to an independent healthcare provider as a NED after being put forward for the role by Luke. Throughout the whole recruitment process I was treated with respect and felt valued. I was particularly impressed with the follow up support after the decision to appoint me, which I have never experienced from other search companies. Luke continued to check in with me to ensure my onboarding went smoothly and that I had settled into the role. Overall, a highly professional and comprehensive approach delivered personally by Luke.”
Priory – Independent Non-Executive Director
“Luke was absolutely brilliant along the journey. He acted as a real partner and was able to answer to all my questions in order to get comfortable with the decision of making the change. His expertise and knowledge of the sector really came out along the process. Most importantly, he was always available when I needed him to be, which is something I valued a lot. In summary, I couldn’t recommend him and Compass Carter Osborne enough.”
AniCura – Group Chief Operating Officer
“We worked with Compass Carter Osborne in the search for our Chief Financial Officer and from the start it was clear they were a good choice of partner. A focus on understanding our needs as a business, and mine personally as a CEO were front of mind for Paul and Kieran. They took the time to listen, understand and not only focus on the functional aspects of the role – but critically, the team fit and culture we are building.
Process, structure and follow-through were like clockwork, and the quality of candidates were of a consistently high-level. I would highly recommend Compass Carter Osborne.”
Renaiss Health – Chief Executive Officer
“I’ve known Tarquin for over 15 years, during which time he has delivered a number of executive assignments at senior level, including COO/executive team and senior management roles in scientific/professional disciplines (his network in the biotech/life-sciences sector is second-to-none!). He works hard to truly understand both the candidate brief and the culture of the company, sets realistic expectations and retains regular contact as an assignment progresses, always providing thorough updates and pragmatic advice. He has the highest levels of professionalism and integrity – he really is a pleasure to work with.”
One Nucleus – Director
“Jamie did a great job – he really took the time to understand our business, our needs and what we were looking for. We knew our brief was specific, yet Jamie met all our expectations with the search. He maintained a high standard of communication and meticulous attention to detail throughout the process. I would recommend Jamie and the Compass Carter Osborne team without hesitation.”
Melrose Education – Chair & CEO
“Our recent work with Compass Carter Osborne was exceptional. The search was perfectly organised, response times were swift, and due to the consultant market knowledge and network, we quickly found our ideal candidate.”
Schoen Clinic – Member of Group Executive
Healthcare news, data and analysis
Via Investors in Healthcare
UK: Priory to acquire Victoria House from Renovo Care Group
Priory, part of Median Group, a provider of mental health, specialist care and rehabilitation services in Germany, the UK and Spain, is expanding its footprint in the UK with the […]
Priory, part of Median Group, a provider of mental health, specialist care and rehabilitation services in Germany, the UK and Spain, is expanding its footprint in the UK with the […]
UK: Priory to acquire Victoria House from Renovo Care Group
October 7, 2025
M&A
M&A Deals
News
Real Estate
Median Group
UK: Trogenix raises £70m Series A to enhance Odysseus
Trogenix, a biotech company dedicated to developing cancer therapies, has completed its Series A financing, raising £70m (US$94m) led by IQ Capital with participation from founding investor 4BIO Capital, returning […]
Trogenix, a biotech company dedicated to developing cancer therapies, has completed its Series A financing, raising £70m (US$94m) led by IQ Capital with participation from founding investor 4BIO Capital, returning […]
UK: Trogenix raises £70m Series A to enhance Odysseus
October 7, 2025
Life Sciences
News
4BIO Capital
Brain Tumor Investment Fund
Calculus Capital
UK: Asker Healthcare acquires Novus Med as bolt-on to HSL
Asker Healthcare Group has acquired Novus Med Holdings, a UK-based distributor of solutions within endoscopic surgery technologies and patient positioning systems, as a bolt-on for HSL Group. “Novus Med is […]
Asker Healthcare Group has acquired Novus Med Holdings, a UK-based distributor of solutions within endoscopic surgery technologies and patient positioning systems, as a bolt-on for HSL Group. “Novus Med is […]
UK: Asker Healthcare acquires Novus Med as bolt-on to HSL
October 5, 2025
Distribution
Healthcare
M&A
News
Asker Healthcare Group
Turning multi-site healthcare platforms into buyer magnets — despite tough markets
Multi-site healthcare continues to attract private equity capital as favourable demographics, recurring demand, and fragmented markets create strong conditions for consolidation, says Jens Brettschneider, a COO and CTO serving on […]
Multi-site healthcare continues to attract private equity capital as favourable demographics, recurring demand, and fragmented markets create strong conditions for consolidation, says Jens Brettschneider, a COO and CTO serving on […]
Turning multi-site healthcare platforms into buyer magnets — despite tough markets
October 5, 2025
Analysis
Healthcare
News
Europe
Jens Brettschneider
Germany: Stefan Verheyden takes up CEO role at Sanner Group
Stefan Verheyden has started in his new role as CEO of the Sanner Group, a Germany-based global supplier of high-quality active packaging solutions and components for the pharmaceutical, diagnostic, nutraceutical […]
Stefan Verheyden has started in his new role as CEO of the Sanner Group, a Germany-based global supplier of high-quality active packaging solutions and components for the pharmaceutical, diagnostic, nutraceutical […]
Germany: Stefan Verheyden takes up CEO role at Sanner Group
October 2, 2025
News
People
Pharma
Services – CRO/CMO/CDMO
Germany
UK: RLAM Property launches £1bn healthcare REIT to accelerate investment in UK care infrastructure
Royal London Asset Management Property (RLAM Property) has launched a £1bn (US$1.35bn) dedicated Healthcare Real Estate Investment Trust (REIT), marking a significant milestone in its strategy to scale investment in […]
Royal London Asset Management Property (RLAM Property) has launched a £1bn (US$1.35bn) dedicated Healthcare Real Estate Investment Trust (REIT), marking a significant milestone in its strategy to scale investment in […]
UK: RLAM Property launches £1bn healthcare REIT to accelerate investment in UK care infrastructure
October 2, 2025
Care Homes
News
Real Estate
Social Care
Mark Evans
Spain: Asabys Partners integrates with Aliath Bioventures life sciences investment platform in strategic move with AltamarCAM
Asabys Partners, a Spanish VC firm specialising in healthcare, and AltamarCAM Partners, a global investment firm specialised in private markets, have agreed to integrate Aliath Bioventures (formerly Alta Life Sciences), AltamarCAM’s life sciences […]
Asabys Partners, a Spanish VC firm specialising in healthcare, and AltamarCAM Partners, a global investment firm specialised in private markets, have agreed to integrate Aliath Bioventures (formerly Alta Life Sciences), AltamarCAM’s life sciences […]
Spain: Asabys Partners integrates with Aliath Bioventures life sciences investment platform in strategic move with AltamarCAM
October 2, 2025
Life Sciences
News
Venture
Aliath Bioventures
Alta Life Sciences
India: Somerset Indus Capital Partners exits Apex Hospitals as InvAscent invests
India-based life sciences-focused private equity firm InvAscent has invested INR2.3bn (US$24m) in Apex Hospitals, a critical care–focused multi-specialty hospital chain headquartered in Jaipur, Rajasthan. “We are excited to partner with […]
India-based life sciences-focused private equity firm InvAscent has invested INR2.3bn (US$24m) in Apex Hospitals, a critical care–focused multi-specialty hospital chain headquartered in Jaipur, Rajasthan. “We are excited to partner with […]
India: Somerset Indus Capital Partners exits Apex Hospitals as InvAscent invests
October 1, 2025
Buy Out
Healthcare
Hospitals and Clinics
M&A
News
US pharma tariffs redirect investment, spreading credit risk unevenly across sector’s value chain
US plans to slap hefty tariffs on pharmaceutical imports have led European firms to speed up US investment and reset supply chains, the full credit impact of which will depend […]
US plans to slap hefty tariffs on pharmaceutical imports have led European firms to speed up US investment and reset supply chains, the full credit impact of which will depend […]
US pharma tariffs redirect investment, spreading credit risk unevenly across sector’s value chain
October 1, 2025
Analysis
News
Pharma
Azza Chammem
Europe
Germany: Ottobock targets €4bn-plus market cap valuation from IPO
Shares in Germany-based prosthetics company Ottobock are to be offered in a tight €62.00 to €66.00 range in its upcoming IPO, valuing the company at between approximately €4bn to €4.2bn. Earlier […]
Shares in Germany-based prosthetics company Ottobock are to be offered in a tight €62.00 to €66.00 range in its upcoming IPO, valuing the company at between approximately €4bn to €4.2bn. Earlier […]
Germany: Ottobock targets €4bn-plus market cap valuation from IPO
September 30, 2025
Life Sciences
Medtech – Medical Devices and Implants
News
Public Equity
BNP Paribas
The Netherlands: Genmab to acquire Merus in anticipation of potential billion-dollar petosemtamab revenues
Denmark-headquartered Genmab, a listed international biotechnology company, is acquiring Netherlands-based Merus, a listed clinical-stage biotechnology company, for US$97.00 per share in an all-cash transaction representing a transaction value of approximately […]
Denmark-headquartered Genmab, a listed international biotechnology company, is acquiring Netherlands-based Merus, a listed clinical-stage biotechnology company, for US$97.00 per share in an all-cash transaction representing a transaction value of approximately […]
The Netherlands: Genmab to acquire Merus in anticipation of potential billion-dollar petosemtamab revenues
September 30, 2025
Debt
M&A
News
A&O Shearman
Bill Lundberg
Spain: Fremman takes over reigns from Portobello to accelerate AGQ expansion
Fremman Capital, a pan-European, mid-market investment firm, has reached a definitive agreement to acquire a stake in AGQ Labs, a Spain-based global testing and analysis laboratory platform, from Portobello Capital, […]
Fremman Capital, a pan-European, mid-market investment firm, has reached a definitive agreement to acquire a stake in AGQ Labs, a Spain-based global testing and analysis laboratory platform, from Portobello Capital, […]
Spain: Fremman takes over reigns from Portobello to accelerate AGQ expansion
September 30, 2025
M&A
News
Pharma
Services – CRO/CMO/CDMO
Venture
Germany: Saesco Medical Group expands into Germany with acquisition of Firma Rivolution
Saesco Medical Group, a medical device distribution group based in Spain, has acquired Germany-based medical technology developer Firma Rivolution. The acquisition will enhance Saesco’s ability to deliver more innovative and […]
Saesco Medical Group, a medical device distribution group based in Spain, has acquired Germany-based medical technology developer Firma Rivolution. The acquisition will enhance Saesco’s ability to deliver more innovative and […]
Germany: Saesco Medical Group expands into Germany with acquisition of Firma Rivolution
September 30, 2025
Life Sciences
M&A
Medtech – Hospital Equipment
News
Germany
UK: Triton-backed Clinigen acquires SSI Strategy from Amulet Capital
UK-based Clinigen, a global, specialist pharmaceutical Services and Products company focused on providing ethical access to medicines, has agreed to acquire SSI Strategy, a provider of strategic consulting services for […]
UK-based Clinigen, a global, specialist pharmaceutical Services and Products company focused on providing ethical access to medicines, has agreed to acquire SSI Strategy, a provider of strategic consulting services for […]
UK: Triton-backed Clinigen acquires SSI Strategy from Amulet Capital
September 29, 2025
Buy Out
M&A
News
Pharma
Services – CRO/CMO/CDMO
Switzerland: Archimed accelerates expansion into biosimilars with acquisition of ExcellGene
Healthcare PE specialist Archimed has acquired a majority stake in Swiss-based, family-owned ExcellGene and sister company Magellan Biologics & Consulting (both in the biologic therapeutics sector), partnering with founders and […]
Healthcare PE specialist Archimed has acquired a majority stake in Swiss-based, family-owned ExcellGene and sister company Magellan Biologics & Consulting (both in the biologic therapeutics sector), partnering with founders and […]
Switzerland: Archimed accelerates expansion into biosimilars with acquisition of ExcellGene
September 29, 2025
Buy Out
M&A
News
ArchiMed
ExcellGene
The Netherlands: Lupin strengthens ophthalmology business with acquisition of VISUfarma from GHO Capital
European specialist investor GHO Capital Partners has announced the sale of its portfolio company, VISUfarma, a pan-European specialty pharmaceutical company focused on ophthalmology, to global pharma major Lupin, at an […]
European specialist investor GHO Capital Partners has announced the sale of its portfolio company, VISUfarma, a pan-European specialty pharmaceutical company focused on ophthalmology, to global pharma major Lupin, at an […]
The Netherlands: Lupin strengthens ophthalmology business with acquisition of VISUfarma from GHO Capital
September 29, 2025
Buy Out
Healthcare
M&A
News
Ophthalmology
Australia: Sonic Healthcare announces CEO succession
ASX-listed Sonic Healthcare, a global provider of laboratory services, pathology, radiology services and primary medical services, has announced that managing director and CEO Dr Colin Goldschmidt will retire at the […]
ASX-listed Sonic Healthcare, a global provider of laboratory services, pathology, radiology services and primary medical services, has announced that managing director and CEO Dr Colin Goldschmidt will retire at the […]
Australia: Sonic Healthcare announces CEO succession
September 29, 2025
Clinical Labs
Healthcare
Life Sciences
Medtech – Diagnostics
News
Ireland: Erisberg completes €175m fundraise for second fund
Erisbeg, an Irish company that acquires and develops established businesses in Ireland and internationally, has confirmed the completion of its fundraise for the €175m Erisbeg II, its second fund focused […]
Erisbeg, an Irish company that acquires and develops established businesses in Ireland and internationally, has confirmed the completion of its fundraise for the €175m Erisbeg II, its second fund focused […]
Ireland: Erisberg completes €175m fundraise for second fund
September 28, 2025
Buy Out
Healthcare
Acanthus Partners
Erisberg
Ireland
Biosimilars: Mansfield Advisors looks at how investors can ‘fill the void’ to drive rapid market growth
Biosimilars is a fast-developing segment of biologics, with recent regulatory changes expected to address development challenges and stimulate market growth. Will Johnson, engagement manager at Mansfield Advisors, and Klaus Martin, […]
Biosimilars is a fast-developing segment of biologics, with recent regulatory changes expected to address development challenges and stimulate market growth. Will Johnson, engagement manager at Mansfield Advisors, and Klaus Martin, […]
Biosimilars: Mansfield Advisors looks at how investors can ‘fill the void’ to drive rapid market growth
September 24, 2025
Analysis
News
Pharma
Klaus Martin
Mansfield Advisors
France: Alpera Partners announces launch as independent investment company
France-based Alpera Partners, previously operating under the name Otium Partners is adopting its own identity as an independent investment company owned by its managers specialising in the construction and financing […]
France-based Alpera Partners, previously operating under the name Otium Partners is adopting its own identity as an independent investment company owned by its managers specialising in the construction and financing […]
France: Alpera Partners announces launch as independent investment company
September 23, 2025
Animal Health
Healthcare
News
Venture
Veterinary
UK: Myricx Bio appoints Mohit Rawat as CEO as it nears the clinic
Myricx Bio, a private biotech company focusing on the discovery and development of a novel class of payloads for antibody-drug conjugates (ADCs), has appointed Mohit Rawat as its CEO as […]
Myricx Bio, a private biotech company focusing on the discovery and development of a novel class of payloads for antibody-drug conjugates (ADCs), has appointed Mohit Rawat as its CEO as […]
UK: Myricx Bio appoints Mohit Rawat as CEO as it nears the clinic
September 23, 2025
Life Sciences
News
People
Mohit Rawat
Myricx Bio
France: PAI said to be readying sale of Ethypharm
Media reports point to PAI Partners selling Ethypharm, a France-based pharmaceutical company with a focus on hospital injectables, pain and addiction treatment, for more than €1bn (US$1.18bn). Jefferies is said to […]
Media reports point to PAI Partners selling Ethypharm, a France-based pharmaceutical company with a focus on hospital injectables, pain and addiction treatment, for more than €1bn (US$1.18bn). Jefferies is said to […]
France: PAI said to be readying sale of Ethypharm
September 22, 2025
M&A
Manufacturing – Specialty Pharma
News
Pharma
Ethypharm
UK: LDC-backed Agentis Health Group launches with first acquisition
Agentis Health Group, a UK-based digital health management specialist, has officially launched following the acquisition of Living With, a digital health company specialising in condition-specific therapeutics and remote patient assessment, […]
Agentis Health Group, a UK-based digital health management specialist, has officially launched following the acquisition of Living With, a digital health company specialising in condition-specific therapeutics and remote patient assessment, […]
UK: LDC-backed Agentis Health Group launches with first acquisition
September 22, 2025
Buy Out
Diagnostics
Digital Health/Healthtech
Distribution
Healthcare
Germany: Vivecti and Sana join forces to create leading European tech-driven procurement network
The Vivecti Group, a portfolio company of Nordic Capital, and Sana Kliniken are entering into a strategic partnership whereby Vivecti is taking over the purchasing group of Sana Kliniken, which […]
The Vivecti Group, a portfolio company of Nordic Capital, and Sana Kliniken are entering into a strategic partnership whereby Vivecti is taking over the purchasing group of Sana Kliniken, which […]
Germany: Vivecti and Sana join forces to create leading European tech-driven procurement network
September 22, 2025
Distribution
Healthcare
M&A
News
Benjamin Behar
Switzerland: Roche to acquire 89bio in deal of up to US$3.5bn
Switzerland-headquartered Roche, the world’s largest biotech company and the global leader in in-vitro diagnostics, is acquiring Nasdaq-listed 89bio, a clinical-stage biopharmaceutical company pioneering the development of innovative therapies for the […]
Switzerland-headquartered Roche, the world’s largest biotech company and the global leader in in-vitro diagnostics, is acquiring Nasdaq-listed 89bio, a clinical-stage biopharmaceutical company pioneering the development of innovative therapies for the […]
Switzerland: Roche to acquire 89bio in deal of up to US$3.5bn
September 19, 2025
IVD – Reagents
Life Sciences
M&A
News
89bio
The latest insights from
Compass Carter Osborne
Attracting US investors: what UK life science companies need to know
Attracting US investors: what UK life science companies need to know
June 10, 2025
Insight
Life Science